Categories: News

Hempu Time innovates CBD- and TCM-contained products with Yunnan Baiyao

BEIJING, April 21, 2022 /PRNewswire/ — This is a news report by China.org.cn about China’s enterprises’ strive to promote traditional Chinese medicine in an innovative way.

Hempu Time Inc., a Chinese hemp company, has been promoting traditional Chinese medicine (TCM) and cannabidiol (CBD) by collaborating with Yunnan Baiyao, a time-honored TCM pharmaceutical company in China.

Hempu Time has synergized TCM and CBD in multiple products, launching its 1st CBD pain relieving spray with a subsidiary of Yunnan Baoyao in November 2021 and pain-away patches in February 2022.

Compared with ordinary topical sprays, the pain-relieving spray distributed by Hempu Time contains CBD, which is documented in studies to be effective in reducing inflammation and alleviating chronic pains. By synergizing with other medicinal herbal ingredients, the Spray reinforces its anti-inflammatory and pain-relieving effects as a transdermal analgesic, according to Ji Han, CEO of Hempu Time.

According to a research conducted by Hempu Time and Yunnan Baiyao, the formulas combining TCM and CBD are conducive to releasing pains and maintaining the inner balance of bodies.

With a history of over 5,000 years, hemp is an important economic crop in China. It has broad applications in medicines, foods, textiles, and cosmetics, said Peng Yuande, a researcher from the Institute of Bast Fiber Crops of the Chinese Academy of Agricultural Sciences. “CBD extracted from hemp is highly effective at treating epilepsy, reported by internationally recognized medical journals,” Peng said.

The medical properties of hemp – a kind of TCM – and CBD are similar, according to Hempu Time.

Back 1,800 years ago, traditional Chinese clinicians were aware of hemp’s effects on pain relief and easing inflammation. Hemp, which CBD is extracted from, is one of the 50 herbs recorded in “Shennong Bencaojing” (“Classic of the Materia Medica”), the oldest Chinese book on agriculture and medicinal plants.

Since discovering the endocannabinoid system (ECS) in the 1990s, scientists have conducted more research and concluded that the ECS, which existed in human bodies and animals, was crucial to stay healthy, and the CBD could regulate the ECS.

Both TCM and Western medicine recognize ECS’s essential role in human physical health. TCM believes that inflammation is the main reason for pains, which corresponds with CBD’s primary function of reducing inflammation.

As modern science probes more into CBD, scientists suggest new methods to combine traditional Chinese herbs and CBD to amplify medical effects. That is what Hempu Time has been striving for during the past decade, Ji said.

Hempu Time innovates CBD- and TCM-contained products with Yunnan Baiyao

http://www.china.org.cn/business/2022-04/21/content_78178815.htm

View original content to download multimedia:https://www.prnewswire.com/news-releases/hempu-time-innovates-cbd–and-tcm-contained-products-with-yunnan-baiyao-301530176.html

SOURCE China.org.cn

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

31 minutes ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

32 minutes ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

35 minutes ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

35 minutes ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

35 minutes ago

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson’s Disease

MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the…

35 minutes ago